Total Payments
$5,292
2024 Payments
$54.64
Companies
30
Transactions
94
Medicare Patients
248
Medicare Billing
$41,156
Payment Breakdown by Category
Food & Beverage$2,905 (54.9%)
Consulting$2,000 (37.8%)
Education$386.95 (7.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,905 | 89 | 54.9% |
| Consulting Fee | $2,000 | 1 | 37.8% |
| Education | $386.95 | 4 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ADC Therapeutics America, Inc. | $2,147 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $435.19 | 6 | $0 (2022) |
| Incyte Corporation | $248.86 | 2 | $0 (2021) |
| Kite Pharma, Inc. | $213.57 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $202.75 | 6 | $0 (2023) |
| EISAI INC. | $200.31 | 6 | $0 (2022) |
| Daiichi Sankyo Inc. | $173.16 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $157.94 | 9 | $0 (2022) |
| Astellas Pharma US Inc | $152.58 | 4 | $0 (2022) |
| Seagen Inc. | $150.04 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54.64 | 3 | W. L. Gore & Associates, Inc. ($40.07) |
| 2023 | $2,286 | 12 | ADC Therapeutics America, Inc. ($2,147) |
| 2022 | $1,359 | 50 | Daiichi Sankyo Inc. ($173.16) |
| 2021 | $1,236 | 22 | AstraZeneca Pharmaceuticals LP ($268.79) |
| 2020 | $266.60 | 6 | Amgen Inc. ($113.07) |
| 2019 | $89.00 | 1 | Seattle Genetics, Inc. ($89.00) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Devices | ||||||
| 01/11/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Devices | ||||||
| 01/09/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Oncology | ||||||
| 12/10/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $17.00 | General |
| 08/23/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2023 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 06/08/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $25.57 | General |
| 06/08/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 04/05/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $12.97 | General |
| 03/15/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Oncology | ||||||
| 02/22/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Oncology | ||||||
| 02/21/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $104.35 | General |
| 01/17/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Oncology | ||||||
| 12/14/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $117.48 | General |
| 12/07/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/30/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Oncology | ||||||
| 11/17/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/16/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 11/09/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: ONC | ||||||
| 11/05/2022 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Oncology | ||||||
| 11/03/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 109 | 204 | $50,575 | $18,133 |
| 2022 | 5 | 139 | 239 | $57,565 | $23,023 |
Total Patients
248
Total Services
443
Medicare Billing
$41,156
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 57 | 129 | $35,475 | $13,281 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 47 | $9,165 | $3,093 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 28 | $5,935 | $1,759 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 40 | 107 | $29,425 | $11,243 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 66 | $12,870 | $4,924 | 38.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 30 | $5,250 | $2,359 | 44.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $5,295 | $2,286 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 21 | 21 | $4,725 | $2,212 | 46.8% |
About Dr. Christopher Graham, MD
Dr. Christopher Graham, MD is a Internal Medicine healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1962864538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Graham, MD has received a total of $5,292 in payments from pharmaceutical and medical device companies, with $54.64 received in 2024. These payments were reported across 94 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,905).
As a Medicare-enrolled provider, Graham has provided services to 248 Medicare beneficiaries, totaling 443 services with total Medicare billing of $41,156. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology
- Location Rochester, MN
- Active Since 03/23/2016
- Last Updated 06/29/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962864538
Products in Payments
- MONJUVI (Drug) $248.86
- Lenvima (Drug) $200.31
- Pomalyst (Drug) $183.69
- KEYTRUDA (Biological) $157.94
- IMBRUVICA (Drug) $150.54
- LYNPARZA (Drug) $144.85
- TECENTRIQ (Biological) $128.75
- Doptelet (Drug) $125.00
- ENHERTU (Drug) $125.00
- TAGRISSO (Drug) $124.47
- DARZALEX (Biological) $120.64
- VYXEOS (Drug) $53.28
- OPDIVO (Biological) $49.94
- INJECTAFER (Drug) $48.16
- EPKINLY (Drug) $42.25
- ENHERTU (Biological) $41.40
- GORE VIABAHN VBX Balloon Expandable Endo (Device) $40.07
- XOSPATA (Drug) $37.52
- DOPTELET (Drug) $35.31
- TUKYSA (Drug) $32.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester
Dr. Ben George, M.d, M.D
Internal Medicine — Payments: $729,795
Internal Medicine $729,795
John Kisiel, M.d, M.D
Internal Medicine — Payments: $550,377
Internal Medicine $550,377
Gregory Poland, M.d, M.D
Internal Medicine — Payments: $532,099
Internal Medicine $532,099
Christopher Ritchlin, Md, MD
Internal Medicine — Payments: $512,889
Internal Medicine $512,889
Scott Feitell, D.o, D.O
Internal Medicine — Payments: $471,187
Internal Medicine $471,187
Prashant Kapoor, Md, MD
Internal Medicine — Payments: $403,295
Internal Medicine $403,295